Ladarixin With Sotorasib in Advanced NSCLC

Clinical trial NCT05815173 · RECRUITING

Trial details

NCT number: NCT05815173
Sponsor: NYU Langone Health
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation

Start date: 2023-08-01
Primary completion: 2027-08-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.